GOVXD - GeoVax Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.2200
-0.2300 (-15.86%)
As of 4:02PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.4500
Open1.4400
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.0500 - 1.4400
52 Week Range0.9000 - 20.0000
Volume10,481
Avg. Volume7,890
Market Cap744,307
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.56
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago

    GeoVax to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019

    ATLANTA, GA, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (GOVXD), a biotechnology company developing human vaccines, announced today that it will be actively engaged in corporate partnering meetings during the BIO International Convention, to be held in Philadelphia on June 3-6, 2019. GeoVax was selected by the National Institutes of Health (NIH) and BIO to exhibit and showcase its technology in a high-profile area of the exhibition floor branded as the Innovation Zone, dedicated to recipients of NIH SBIR/STTR grants.

  • GlobeNewswire2 months ago

    GeoVax Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11

    ATLANTA, GA, May 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (GOVXD), a biotechnology company developing human vaccines, announced today its observance of HIV Vaccine Awareness Day on May 18. HIV Vaccine Awareness Day is observed each year to recognize the many volunteers, community members, health professionals, and scientists working to develop a vaccine to prevent HIV. It is also an opportunity to educate communities about the importance of preventive HIV vaccine research.

  • GlobeNewswire2 months ago

    GeoVax to Present Unique Technology at New York Academy of Sciences Vaccine Conference

    ATLANTA, GA, May 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (GOVXD), a biotechnology company developing human vaccines, announced that it will deliver a presentation showcasing the Company’s unique technology during the Innovative Vaccines Against Resistant Infectious Diseases and Emerging Threats Conference, presented by the Microbiology and Infectious Diseases Discussion Group of The New York Academy of Sciences.

  • GlobeNewswire2 months ago

    GeoVax Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress

    ATLANTA, May 14, 2019 -- GeoVax Labs, Inc. (OTCQB: GOVXD), a biotechnology company developing human vaccines, today announced its financial results for the three months ended.